Anúncio

approach to anemia.pptx

Gadeppa H
Student at Hassan Institute of Medical Sciences
26 de Mar de 2023
Anúncio

Mais conteúdo relacionado

Anúncio

approach to anemia.pptx

  1. APPROACH TO ANEMIA Guided by Dr SHIDRAM K sir Presented by -Dr Gadeppa
  2. Definition of Anemia Anemia – The World Health Organisation defines anemia as a hemoglobin level <13gm/dl in men and <12 gm/dlin women.
  3. Adult male <13 Adult Female <12 Pregnant Female <11 Newborn <14
  4. Erythron • • Erythron is the machinery of RBC production EPO, IL, Growth factors, Cytokines – stimulate it • Hypoxia is strong stimulus for the Erythron • Its functioning is influenced by 1. Normal renal production of EPO 2. A functioning Erythroid marrow 3. An adequate supply of substrates for Hb production
  5. ERYTHROPOIETIN • Glycoprotein hormone • Produced by peritubular capillary lining of cells in kidney • Small amount in liver • EPO gene regulation is by Hypoxia inducible factor 1α • Normal levels 10 – 25 U/l • T1/2 – 6-9 hrs
  6. Normal Red Cells Nonucleus, Enzymepackets Biconcavediscs–Haem+Gl Center1/3pallor Pinkcytoplasm(Hbfilled) Cellsize7- 8µm
  7. Hemoglobin (Hb)
  8. EVALUATION- HISTORY • Age/Sex • Rate of onset - Rapid/Slow • Blood loss - Haematemesis/malena/bleeding piles/menorrhagia/ metorrhagia/epistaxis/hematuria /haemoptysis • Abdomen - Appetitie/weight loss/dysphagia/regurgitation/dyspepsia/ abd pain/diarrhoea/constipation/jaundice/soreness of tongue/previous abd surgeries • Reproductive - Menstrual history in detail/number & interval between pregnancies/miscarriages • Urinary system - Nocturnal polyuria • CNS-Parasthesiae / difficulty in walking
  9. EVALUATION- HISTORY • Bleeding tendency - Easy bruising / prolonged bleeding after trivial injuries/bleeding from more than one site • Skeletal system - Bone pain / Arthritis / Arthralgia • Temperature - Fever / Night sweats • Drug ingestion - Previuos / current • Occupation - Metal dusts / solvent fumes / lead • Diet • Social history – Alcoholism • Past H/o-Previous anaemia: diag & Rx, response to Rx • Family H/o-Anaemia / recurrent jaundice / IUD & childhood deaths
  10. EVALUATION - EXAMINATION: • Skin - Colour, texture, petechiae, ecchymoses, scratch marks. • Nails - Brittleness, longitudinal ridging, koilonychia • Conjunctiva/Sclera - Pallor, icterus, haemorrhages • Retina - Haemorrhages, s/o HTN/renal failure, other changes • Mouth - Mucous membrane: Pallor, petechiae • Gums: Bleeding, hypertrophy • Tongue: Redness, atrophy of papillae • Abdomen - HSM, either HM or SM, tenderness, mass, ascites • CVS-BP, valvular, vascular prosthesis • CNS- Peripheral neuritis, s/s/o SADSC
  11. EVALUATION - EXAMINATION: • Supf LN- Enlargement of cervical, axillary, inguinal, epitrochlear nodes • Bones - Tenderness (esp. of sternum), tumour • Legs - Ulcers / scars of healed ulcers • P/R-Haemorrhoids / CA Rectum • Pelvic - Menorrhagia, metorrhagia, uterus, cervix
  12. WORK UP FOR ANEMIA
  13. The Three Basic Measures Measurement Normal Range A. RBC count 5 million 4 to 6 B. Hemoglobin 15 g% 12 to 17 C. Hematocrit 45 38 to 50
  14. The Three Derived Indicies Measurement A. RBC count Normal 5 million Range 4 to 6 B. Hemoglobin 15 g% 12 to 17 C. Hematocrit 45 38 to 50 MCV C ÷ A x 10 = 90 fl MCH B ÷ A x 10 = 30 pg MCHC B ÷ C x 100 = 33%
  15. RETICULOCYTE COUNT % • Reticulocytes are immature RBC • ‘RBC to be’ or Apprentice RBC • Fragments of nuclear material • RNA strands which stain blue • Normal Less than 2%
  16. Reticulocytes Leishman’s Supravital
  17. Reticulocyte correction • Correction 1 - in presence of anemia, reticulocyte count spuriously elevated when it is related to reduced number of RBCs in anemic patient. (relatively more in number due to reduced mature RBC) • Correction 2 - An additional correction needs to be made because reticulocytes released under intense EPO stimulation remain in the peripheral blood for more than usual 1 day (prematurely released Reticulocyte remains longer in circulation) Reticulocyte count %of reticulocytes in RBC population Corrected reticulocyte count %reticulocytes ×(patient Hct/45) Reticulocyte production index Corrected reticulocyte count ÷ maturation time in peripheral blood in days Absolute reticulocyte count %reticulocytes ×RBC count/L
  18. CORRECTED RETICULOCYTE COUNT
  19. Red cell distribution width • RDW measures range of variation of red cell volume • Normal range is 11.5 to 14.5 % • It is measure of anisocytosis • Usually elevated in deficiency of Iron, Folate, B12 • Usually normal in Hemoglobinopathy
  20. RBC Size – Anisocytosis Different sizes of RBC
  21. MENTZERS INDEX • MCV/RBC • >13 - S/O IRON DEFICIENCY ANEMIA • 11-13 - INDETERMINATE • <11 - THALASSEMIA TRAIT
  22. Peripheral Smear Study • Are all RBC of the same size ? • Are all RBC of the same normal discoid shape ? • How is the colour (Hb content) saturation ? • Are all the RBC of same colour/ multi coloured ? • Are there any RBC inclusions ? • Are intra RBC there any hemo-parasites ? • Are leucocytes normal in number and D.C ? • Is platelet distribution adequate ?
  23. Cell size Hb content Anisocytosis Poikilocytosis Polychromasia Gives clues to specific disorders Normal peripheral smear
  24. Severe Iron defeciency anemia Anisocytosis (size), Poikilocytosis (shape) Macrocytosis Macrocytes, Ovalocytes Myelofibrosis Tear drop shaped cells, nucleated cells Thallassemia Target cells
  25. Howell-Jolly bodies Red cell fragmentation Uremia Spur cells
  26. Target Cells 1. Liver Disease 2. Thalassemia 3. HbDDisease 4. Post splenectomy
  27. Shistocytes Fragmented, Helmet or triangle shaped RBC 1. MAHA 2. Prosthetic valves 3. Uremia 4. Malignant HT
  28. Tear Drop Cells 1. Myelofibosis 2. Infiltration of BM 3. Tumours of BM 4. Thalassemia
  29. Types of Anaemia
  30. Mean Cell Volume (MCV) measured by M and RDW Microcytic < 80 fl MCV Normocytic CV Macrocytic 80 -100 fl > 100 fl < 6.5 µ 6.5 - 9 µ > 9 µ
  31. Anaemia Workup - MCV Microcytic MCV Normocytic Macrocytic IronDeficiency IDA Chronic Infections Thalassemias Hemoglobinopathies SideroblasticAnemia Chronic disease Early IDA Hemoglobinopathies Combined deficiencies Increaseddestruction Megaloblastic anemias Liver disease/alcohol Hemoglobinopathies Marrowdisorders Increaseddestruction
  32. Hypoproliferative Anaemias Failureofcell maturation Nuclear breakdown Cytoplasmi c breakdown MegaloblasticAnaemia DefectiveDNAsynthesis FolateorB12 deficiency Haemdefect Globindefect Thalassemia SicklecellA Fe Phorph IDA, SA
  33. IDA – Special Tests Iron related tests Normal IDA Serum Ferritin (pmo/L) 33-270 < 33 TIBC (µg/dL) 300-340 > 400 Serum Iron (µg/dL) 50-150 < 30 Saturation % 30-50 < 10 Bone marrow Iron ++ Absent
  34. Microcytic Anaemias MCV < 80 fl Serum Iron TIBC BM Perls stain Iron Def. Anemia ↓↓ ↑↑ 0 Chronic Infection ↓↓ ↓↓ + + Thalassemia ↑↑ N + + + + Lead poisoning N N + + Sideroblastic ↑↑ N + + + +
  35. IDA • Microcytic • RDW • Hypochromic • RPI • Serum ferritin • TIBC • Serum Iron • BM Fe Stain • Response to Fe Rx. MCV < 80 fl, RBC < 6 µ Widened and shift to left MCH < 27 pg, MCHC < 30% < 2 Very low < 30 (p mols/L) Increased > 400 (µg/dL) Very low < 30 (µg/dL) Absent Fe Excellent
  36. IDA • Look for occult blood loss – 2 days non veg. free • Pica and Pagophagia • Absorption of Haem Iron > Fe++ • Food, Phytates, Ca, Phosphate, antacids ↓absorption • Ascorbic acid ↑absorption • Oral iron Rx. always is the best
  37. • Oral iron therapy. • Packed cell transfusion in emergency • Continue Fe Rx at least 2 months after normal Hb • 1 gram ↑in Hb every week can be expected • Always supplement protein for the Globin component
  38. Microcytic Hypochromic - IDA
  39. Severe Hypochromia
  40. Ringed Sideroblasts in BM PrussianBlueStain
  41. Macrocytic Anaemias • Megaloblastic Macrocytic –B12 and Folate↓ • Non Megaloblastic Macrocytic Anaemias 1. Liver disease/alcohol 2. Hemoglobinopathies 3. Metabolic disorders, Hypothyroidism 4. Myelodystrophy, BM infiltration 5. Accelerated Erythropoesis -↑destruction 6. Drugs (cytotoxics, immunosuppressants, AZT, anticonvulsants)
  42. Anemia - Macrocytic (MCV > 100) – Macrocytic anemias may be asymptomatic until the Hb is as low as 6 grams – MCV 100-110 fl must look for other causes of macrocytosis – MCV > 110 fl almost always folate or B12 deficiency
  43. Macrocytosis of Alcoholism • MCV elevation usually slight (100-110 fl) • Minimal or no anemia • Macrocytes round (not oval) • Neutrophil hyper segmentation absent • Folate stores normal
  44. DRUGS CAUSING MEGALOBLASTICANEMIA  Folate antagonists (e.g., methotrexate)  Purine antagonists (e.g., 6-mercaptopurine)  Pyrimidine antagonists (e.g., cytosine arabinoside)  Alkylating agents (e.g., cyclophosphamide)  Zidovudine (AZT , Retrovir)  Trimethoprim  Oral contraceptives  Nitrous oxide  Arsenic
  45. Megaloblastic Hematopoiesis Marrow failure due to • Disrupted DNA synth. & ineffective erythropoesis • Giant precursors (Megaloblasts) • Nuclear : Cytoplasmic dyssynchrony in marrow • Neutrophil hyper segmentation & macro ovalocytes • Anemia (and often leukopenia & thrombocytopenia) • Almost always due to B12 or folate deficiency
  46. Pernicious Anaemia - Tongue Bald, smooth, lemon yellowish red tongue
  47. Megaloblastic anemia
  48. Anisocytosis - Macrocytic Anaemia
  49. Normocytic Anaemias • Chronic disease • Early IDA • Hemoglobinopathies • Primary marrow disorders • Combined deficiencies
  50. Anaemia of Chronic Disease • Thyroid diseases • Malignancy • Collagen Vascular Disease – Rheumatoid Arthritis – SLE – Polymyositis – Polyarteritis Nodosa • IBD – Ulcerative Colitis – Crohn’s Disease • Chronic Infections – HIV, Osteomyelitis – Tuberculosis • Renal Failure
  51. • Anaemia is usually mild and non-progressive, rarely less than 9 gm/dL. • Anaemia is never severe • Anaemia resolves when underlying cause is treated. • Anaemia of chronic inflammation is not responsive to haematinics like iron, folate, vitamin B12. • Transfusion is rarely indicated. • Higher doses of Epo is required to treat ACD than for the therapy of renal anaemia.
  52. ‘Dimorphic’ Anaemia • Folate & Fe deficiency (pregnancy, alcoholism) • B12 & Fe deficiency (PA with atrophic gastritis) • Thalassemia minor & B12 or folate deficiency • Fe deficiency & hemolysis (prosthetic valve) • Folate deficiency & hemolysis (Hb SS disease) • Peripheral smear exam is critical to assess these • RDW is increased very much
  53. Hemolytic Anaemia Anemia of increased RBC destruction – Normochromic, normocytic anemia – Shortened RBC survival – Reticulocytosis – due to ↑ RBC destruction Will not be symptomatic until the RBC life span is reduced to 20 days – BM compensates 6 times
  54. Tests Used to Diagnose Hemolysis 1. Reticulocyte count 2. Combined with serial Hb 3. Serum LDH 4. Serum bilirubin 5. Haptoglobin 6. Urine hemosiderin 7. Hemoglobinuria
  55. Findings in Hemolytic Anaemia Reticulocyte count and RPI Increased Serum Unconjugated Bilirubin Increased Serum LDH 1: LDH 2 Increased Serum Haptoglobin Decreased Urine Hemoglobin Present Urine Hemosiderin Present Urine Urobilinogen Increased Cr 51 labeled RBC life span Decreased
  56. Tests to define the cause of hemolysis 1. Hemoglobin electrophoresis 2. Hemoglobin A2 (βeta-Thalassemia trait) 3. RBC enzymes (G6PD, PK, etc) 4. Direct & indirect antiglobulin tests (immune) 5. Cold agglutinins 6. Osmotic fragility (spherocytosis) 7. Acid hemolysis test (PNH) 8. Clotting profile (DIC)
  57. Spherocytosis
  58. Elliptocytes Hereditary Elliptocytosis, B12 or Folate↓
  59. Sickle Cell Anaemia
  60. Micro Angiopathic Hemolytic Anaemia
  61. ANEMIA DUE TO IMPAIRED BONE MARROW RESPONSE Red blood cell aplasia Aplastic anemia Myelodysplasia Leukemias Myelophthisic anemia Marrow infiltration Myeloma Congenital Dyserythropoietic Anemias
  62. Aplastic Anaemia 1. Chloramphenicol 2. Carbimazole 3. Sulfonamides 4. Phenytoin 5. Anti Ca drugs
  63. BM - Aplastic Anaemia
  64. ↓ HB RETIC COUNT
  65. CONDITION SERUM IRON TIBC FERRITIN COMMENT Iron deficiency ↓ ↑ ↓ Responsive to iron Chronic inflammation ↓ ↓  Unresponsive to iron Thalassemia major ↑ N N Reticulocytosis and indirect bilirubinemia Lead poisoning N N N Basophilic stippling of RBCs Sideroblastic anemia ↑ N  Ring sideroblasts in marrow
  66. ↓ HB
  67. RPI <2.5 RPI >2.5 • Anemia of chronic disease • CKD • Acute Bloodloss • Leukemia • Approach to Pancytopeni a • Approach to Hemolytic anemia
  68. ↓ HB RETIC COUNT
  69. REFERENCES • Harrison’s Principles of Internal Medicine 20th edition • The Washington’s Manual of Medical Therapeutics 34th edition • Robbins & Cotran Pathologic Basis of Disease, 8th edition
Anúncio